Globe Newswire

Sales, adjusted operating income, adjusted EPS at the high end or above guidance

Reaffirms fiscal 2024 sales and adjusted operating income guidance

REYNOLDSBURG, Ohio, May 09, 2024 (GLOBE NEWSWIRE) -- Victoria’s Secret & Co. (“Victoria’s Secret” or the “Company”) (NYSE: VSCO) today provided preliminary results for the first quarter 2024 ended May 4, 2024. Net sales, adjusted operating income, and adjusted diluted earnings per share for the first... (continue reading...)

NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against DoubleVerify, Inc (“DoubleVerify” or the “Company”) (NYSE: DV). The investigation concerns whether DoubleVerify and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

[Click here to learn more about the investigation]

On May 7, 2024, DoubleVerify announced its financial... (continue reading...)

CALGARY, Alberta, May 09, 2024 (GLOBE NEWSWIRE) -- Source Energy Services Ltd. (TSX: SHLE) (“Source” or the “Company”) is pleased to announce its financial results for the three months ended March 31, 2024.

Q1 2024 PERFORMANCE HIGHLIGHTS

Key achievements for the quarter ended March 31, 2024 include the following:

• realized sand sales volumes of 874,849 metric tonnes (“MT”) and sand revenue of $133.0 million, an increase of $1.2 million from the... (continue reading...)

ARR up 21% YoY to $47.8 millionTotal Revenue up 21% to $15.3 millionEBITDA up 56% YoY to $3.1 million

TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX: VHIBF) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and Analysis report for the three ended March 31, 2024, with the Canadian securities authorities. These documents may be viewed... (continue reading...)

SoCal-based Clinical-Stage Biopharmaceutical Company Focused on Novel Therapeutics for Brain and Central Nervous System Diseases Nominated for Breakthrough Medical Technology Achievement Award

LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc., a clinical stage biopharmaceutical company, is proud to be presenting at the 2024 California Investment Forum (CIF), which will take place May 8-11 at the Anaheim Majestic Garden Hotel in Anaheim,... (continue reading...)